US42805E3062 - HSKA - A1H5J3 (XNCM)
HESKA CORP Action
Pas de cours
Performance
Jour | Semaine | Mois | 3 mois | 6 mois | 1 an | 5 ans |
---|---|---|---|---|---|---|
- | - | - | - | 0,00 % | 0,00 % | 24,39 % |
Profil de l'entreprise pour HESKA CORP Action
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; and turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force, and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was founded in 1988 and is based in Loveland, Colorado.
Fonds investis
Les fonds suivants ont investi dans : HESKA CORP investi :
Fonds | Vol. en millions 84,80 | Part (%) 0,15 % |
Données de l'entreprise pour HESKA CORP Action
Nom HESKA CORP
Société Heska Corporation
Symbole HSKA
Site web https://www.heska.com
Marché d'origine
NASDAQ CAPITAL MARKET
WKN A1H5J3
ISIN US42805E3062
Type de titre Action
Secteur Healthcare
Industrie Medical - Devices
PDG Mr. Kevin S. Wilson
Capitalisation boursière 1 Mrd.
Pays États-Unis d'Amérique
Devise USD
Employés 0,8 T
Adresse 3760 Rocky Mountain Avenue, 80538 Loveland
Date d'introduction en bourse 1997-07-01
Dividendes de 'HESKA CORP'
Date ex-dividende | Dividende par action |
---|---|
26.09.2012 | 0,10 USD |
27.06.2012 | 0,10 USD |
28.03.2012 | 0,10 USD |
Fractionnements d'actions
Date | Fractionnement |
---|---|
30.12.2010 | 1:10 |
Changements d'identifiant
Date | De | À |
---|---|---|
31.01.2011 | HSKAD | HSKA |
Symboles boursiers
Nom | Symbole |
---|---|
NASDAQ | HSKA |
Autres actions
Les investisseurs qui détiennent HESKA CORP ont également les actions suivantes dans leur portefeuille :
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles.
Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.